A single-component research material supplied for controlled research environments. Mazdutide (100 mg) is a dual GLP-1/GCG receptor agonist analog designed for advanced studies investigating glucose metabolism, energy balance, and weight regulation pathways in controlled preclinical models.

• Significant Weight Loss: Trials demonstrate consistent, dose-dependent weight reduction, with 12 weeks of treatment showing BMI reductions of up to 10.99%.
• Improved Metabolic Parameters: Beyond weight loss, it significantly improves metabolic indicators, including systolic/diastolic blood pressure, reduced triglycerides, LDL cholesterol, and improved HDL levels.
• Glucose Regulation: Mazdutide shows superior glucose-lowering effects (lower HbA1c) compared to semaglutide, making it effective for type 2 diabetes management.
• Liver Fat Reduction: Studies (GLORY-1) showed an 80.2% reduction in liver fat content in exploratory analysis, targeting metabolic dysfunction-associated fatty liver disease (MAFLD).
• Increased Energy Expenditure: Unlike treatments that only suppress appetite, mazdutide’s glucagon component helps increase energy expenditure.
• Reduced Waist Circumference: Participants saw marked reductions in waistline.
• Potential Cognitive Benefits: Research indicates that the dual mechanism of action may help improve cognitive function associated with obesity and diabetes. 
  PubMed Central (PMC) (.gov) +10

Composition

• Mazdutide
• Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• In-vitro and in-vivo studies on GLP-1 and glucagon receptor signaling
• Evaluation of Mazdutide’s effects on glucose regulation and lipid metabolism in model systems
• Analytical method development (HPLC/LC-MS) for peptide purity and identity verification
• Stability and solubility characterization of Mazdutide under laboratory storage conditions

For qualified research professionals and institutional laboratories. Not for human use.

Documentation & Quality Assurance

Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.

Important Notice

This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.

Quality & Manufacturing

All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.

We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.

All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.